View in EDS PDF Full Text

Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.

Saved in:
Bibliographic Details
Title: Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.
Authors: Klepsch V; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria., Hermann-Kleiter N; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria., Do-Dinh P; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria., Jakic B; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria., Offermann A; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck and Research Center Borstel, Leibniz Lung Center, 23538, Leubeck, Germany., Efremova M; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria., Sopper S; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria., Rieder D; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria., Krogsdam A; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria., Gamerith G; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria., Perner S; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck and Research Center Borstel, Leibniz Lung Center, 23538, Leubeck, Germany., Tzankov A; Department of Pathology, University of Basel, University Hospital Basel, 4031, Basel, Switzerland., Trajanoski Z; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria., Wolf D; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.; Medical Clinic III, Oncology, Hematology & Rheumatology, University Clinic Bonn, 53127, Bonn, Germany., Baier G; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria. gottfried.baier@i-med.ac.at.
Source: Nature communications [Nat Commun] 2018 Apr 18; Vol. 9 (1), pp. 1538. Date of Electronic Publication: 2018 Apr 18.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29670099
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Klepsch+V%22">Klepsch V</searchLink>; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Hermann-Kleiter+N%22">Hermann-Kleiter N</searchLink>; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Do-Dinh+P%22">Do-Dinh P</searchLink>; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Jakic+B%22">Jakic B</searchLink>; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Offermann+A%22">Offermann A</searchLink>; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck and Research Center Borstel, Leibniz Lung Center, 23538, Leubeck, Germany.<br /><searchLink fieldCode="AU" term="%22Efremova+M%22">Efremova M</searchLink>; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Sopper+S%22">Sopper S</searchLink>; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Rieder+D%22">Rieder D</searchLink>; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Krogsdam+A%22">Krogsdam A</searchLink>; Biocenter, Division of Bioinformatics, Medical University of Innsbruck, 6030, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Gamerith+G%22">Gamerith G</searchLink>; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Perner+S%22">Perner S</searchLink>; Pathology of the University Hospital Schleswig-Holstein, Campus Luebeck and Research Center Borstel, Leibniz Lung Center, 23538, Leubeck, Germany.<br /><searchLink fieldCode="AU" term="%22Tzankov+A%22">Tzankov A</searchLink>; Department of Pathology, University of Basel, University Hospital Basel, 4031, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Trajanoski+Z%22">Trajanoski Z</searchLink>; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Wolf+D%22">Wolf D</searchLink>; Tumor Immunology, Tyrolean Cancer Institute & Internal Medicine V, 6020, Innsbruck, Austria.; Medical Clinic III, Oncology, Hematology & Rheumatology, University Clinic Bonn, 53127, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Baier+G%22">Baier G</searchLink>; Division of Translational Cell Genetics, Medical University of Innsbruck, 6020, Innsbruck, Austria. gottfried.baier@i-med.ac.at.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2018 Apr 18; Vol. 9 (1), pp. 1538. <i>Date of Electronic Publication: </i>2018 Apr 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29670099
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-018-04004-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1538
    Titles:
      – TitleFull: Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Klepsch V
      – PersonEntity:
          Name:
            NameFull: Hermann-Kleiter N
      – PersonEntity:
          Name:
            NameFull: Do-Dinh P
      – PersonEntity:
          Name:
            NameFull: Jakic B
      – PersonEntity:
          Name:
            NameFull: Offermann A
      – PersonEntity:
          Name:
            NameFull: Efremova M
      – PersonEntity:
          Name:
            NameFull: Sopper S
      – PersonEntity:
          Name:
            NameFull: Rieder D
      – PersonEntity:
          Name:
            NameFull: Krogsdam A
      – PersonEntity:
          Name:
            NameFull: Gamerith G
      – PersonEntity:
          Name:
            NameFull: Perner S
      – PersonEntity:
          Name:
            NameFull: Tzankov A
      – PersonEntity:
          Name:
            NameFull: Trajanoski Z
      – PersonEntity:
          Name:
            NameFull: Wolf D
      – PersonEntity:
          Name:
            NameFull: Baier G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 04
              Text: 2018 Apr 18
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1